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Host Responses to Group A Streptococcus: Cell Death
and Inflammation
James A. Tsatsaronis1, Mark J. Walker2, Martina L. Sanderson-Smith1*
1 Illawarra Health and Medical Research Institute (IHMRI), School of Biological Sciences, University of Wollongong, Wollongong, New South Wales, Australia, 2 Australian
Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Queensland, Australia
Abstract: Infections caused by group A Streptococcus
(GAS) are characterized by robust inflammatory responses
and can rapidly lead to life-threatening disease manifes-
tations. However, host mechanisms that respond to GAS,
which may influence disease pathology, are understudied.
Recent works indicate that GAS infection is recognized by
multiple extracellular and intracellular receptors and
activates cell signalling via discrete pathways. Host
leukocyte receptor binding to GAS-derived products
mediates release of inflammatory mediators associated
with severe GAS disease. GAS induces divergent
phagocyte programmed cell death responses and has
inflammatory implications. Epithelial cell apoptotic and
autophagic components are mobilized by GAS infection,
but can be subverted to ensure bacterial survival.
Examination of host interactions with GAS and conse-
quences of GAS infection in the context of cellular
receptors responsible for GAS recognition, inflammatory
mediator responses, and cell death mechanisms, high-
lights potential avenues for diagnostic and therapeutic
intervention. Understanding the molecular and cellular
basis of host symptoms during severe GAS disease will
assist the development of improved treatment regimens
for this formidable pathogen.
Introduction
Group A Streptococcus (GAS; Streptococcus pyogenes) is a
clinically important bacterial pathogen responsible for many
severe human diseases. Whilst GAS is a frequent agent of self-
limited pharyngitis and uncomplicated impetigous infections,
penetration of GAS into deeper tissues, trauma, or adverse
progression of superficial tissue infections can result in devastating
invasive infections, such as the ‘‘flesh-eating’’ syndrome, necrotis-
ing fasciitis (NF), or more rarely, myonecrosis [1,2]. Systemic
manifestations of GAS disease, sepsis, or streptococcal toxic shock
syndrome (STSS), when accompanying invasive cutaneous infec-
tions, strongly contribute to poor patient prognosis [3]. Conser-
vative estimates of the global burden of severe GAS diseases
account for 663,000 cases, with 32% of NF cases resulting in
patient mortality within seven days in developed countries, rising
to a 50% case mortality rate in NF episodes with associated STSS
[4,5]. The destructive nature, rapid onset, and high mortality rate
of severe GAS diseases, such as NF and STSS, despite prompt
medical care and antimicrobial therapy, necessitates an improved
understanding of the mechanisms underlying these pathologies.
Whilst mechanisms by which GAS evades elements of the innate
immune response have been the focus of intense investigation [6],
comparatively less attention has been given to the host processes
underlying the pathophysiology of GAS infections. Notably, the
roles of cellular host mediators in the context of GAS infection are
poorly understood. Here, we integrate recent works describing
cellular recognition of GAS infection, signalling pathways leading
to inflammatory mediator release and consequent programmed
cell death mechanisms. A holistic perspective, incorporating the
role of host factors in GAS diseases, should enable the
development of more efficacious and tailored treatment options.
Leukocyte Recognition of GAS and Signalling
Pathways
Toll-like receptor recognition
Cellular surveillance and recognition of foreign agents by the
innate immune system is an essential prerequisite to effector
recruitment and induction of appropriate responses. One class of
cell receptors involved in recognition of highly conserved
microbial components are the Toll-like receptors (TLRs). There
are currently more than 10 known TLRs, which recognize
multiple pathogen-associated molecular patterns (PAMPs), includ-
ing lipoteichoic acid (LTA), peptidoglycan (TLR2), lipopolysac-
charide (TLR4), and unmethylated bacterial CpG DNA (TLR9)
[7]. Studies investigating receptors involved in recognition of GAS
infection have shown that TLR signalling, particularly through the
MyD88 adapter molecule, plays a vital role in induction of host
defences and inflammation (Figure 1) [8,9]. Given that TLR2
recognises multiple gram-positive bacterial ligands, it is likely this
TLR plays a major role in GAS recognition and responses.
Indeed, induction of streptococcal cell wall extract–induced joint
inflammation is dependent on TLR2/MyD88 signalling [10].
Leukocyte signaling events
Macrophages and dendritic cells (DCs) are commonly viewed as
central coordinators of immune responses. This view has been
supported by studies showing that macrophages and DCs are both
essential for control of GAS infection [11,12], likely through
secretion of multiple pro-inflammatory cytokines such as interleukin
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(IL)-1b, IL-6, tumour necrosis factor (TNF)-a, and IL-12 [9,13].
Macrophage and DC recognition of GAS is partially mediated
by TLRs, and interaction with multiple bacterial factors by
different TLRs appears to provide immune redundancy in
inducing cytokine responses. This redundancy is exemplified by
the activation of macrophages via TLR4 signalling from
nonstructural bacterial elements, such as GAS cytolysin strep-
tolysin O (SLO), and the inability of singular TLR1, TLR2,
TLR4, or TLR9 deficiencies to prevent stimulation of DC
cytokine production [12,14]. However, downstream MyD88
signalling is critical for coordinated immune responses, an aspect
prominent in clinical studies of patients lacking MyD88, who
are highly predisposed to pyogenic infections [15]. MyD88
participates in macrophage and DC TLR-stimulated TNF-a
production and type-1 interferon (IFN) responses [8,9,16,17].
GAS induction of IFN-b is nucleic acid–dependent and requires
interferon regulator factor (IRF) 3, IRF5, stimulator of
interferon genes (STING), and TANK-binding kinase (TBK) 1
signalling via as-yet-undescribed receptors [16,17]. Although
GAS is typically considered an extracellular pathogen [1], recent
studies indicate intracellular receptors, such as TLR9, are
important for cytokine responses via hypoxia-inducible factor 1-
alpha (HIF-1a) signalling, and also contribute to macrophage
GAS killing and reactive oxygen species (ROS) production [18].
Non-TLR recognition of GAS
Other non-TLR receptors have been shown to respond to GAS
infection. Secretion of SLO mediates activation of the intracellular
NOD-like receptor (NLRP) inflammasome component NLRP3
and promotes macrophage caspase-1 mediated IL-1b secretion
independently of both TLR and MyD88 signalling [19]. A recent
report describes secondary modulation of macrophage cytokine
responses by the triggering receptor expressed on myeloid cells
(TREM)-1, which, when inhibited, has a therapeutic effect in
murine models of GAS sepsis [20]. The recent work of Baruch et
al. demonstrates SLO-mediated host signalling via induction of
endoplasmic reticulum stress [21]. Adherence of sil-expressing
GAS to epithelial cells and macrophages increases host asparagine
Figure 1. Cellular receptors and signalling pathways involved in GAS recognition and inflammatory mediator release. Inflammatory
mediators are released from multiple leukocyte types during GAS infection; including PMNs, monocytes, macrophages, and dendritic cells [12,13].
GAS and GAS-derived LTA, SLO, and soluble M1 protein (sM1), activate cellular responses to infection [14,26]. Receptors involved in recognition of
GAS include TLRs, TREM-1, complement receptors (CR), immunoglobulin receptors (FcR), Mac-1, and NLRP3 [9,19,20,27]. Ligand binding to these
receptors leads to downstream signalling via MyD88, HIF-1a, STING, IFR3, IRF5, and TBK1 [8,16–18]. Recognition of GAS triggers release of
interleukins, TNF-a, IFN-b, HBP, resistin, and LL-37 [16,25].
doi:10.1371/journal.ppat.1004266.g001
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synthetase expression and asparagine production, driving GAS
proliferation and virulence [21].
Excessive Host Responses Contributing to GAS
Disease Pathology
Superantigenic stimulation of T-cell responses
Sufficient excitation of host defences is necessary to mount an
adequate response to combat GAS infection. A large body of
evidence suggests, however, that excessive and misdirected host
responses underlie damaging pathologies of severe GAS infection
[22]. GAS may produce one or more of a large variety of
superantigens that increase host propensity to excessive immune
activation. Superantigens circumvent conventional antigen pre-
sentation by binding simultaneously to both the major histocom-
patibility complex (MHC) class II and T-cell receptors outside of
the peptide-binding area [23]. The resulting ‘‘cytokine storm’’,
driven by activated T-cells and antigen presenting cells, may
underlie host hyperinflammatory responses [22]. While GAS
superantigens play an important role in dictating immune
responses, exhaustive discussion of these protein toxins is beyond
the scope of this article, and the reader is directed to recent
comprehensive reviews [22–24].
M1-mediated heparin binding protein release
Interactions of polymorphonuclear leukocytes (PMNs) and the
classic GAS virulence factor, M protein, have been recently
implicated in mediating excessive inflammatory responses [25]. As
the major effector cell type of the innate immune system,
activation of PMNs and the release of cytotoxic granules has
implications for development of severe GAS diseases pathologies.
Serotype M1 protein released from the GAS cell surface forms
complexes with fibrinogen that bind to PMN Mac-1 receptor, both
activating PMNs and triggering release of heparin binding protein
(HBP) (Figure 1) [26]. HBP is a potent inducer of vascular
permeability, and release of this protein elicits pulmonary lesion
formation and vascular leakage [26]. PMN-mediated HBP release
synergistically enhances inflammatory cytokine responses from M1
protein–stimulated peripheral blood monocytes during necrotizing
infections [27]. Individuals with IgG antibodies directed towards
the central region of the M1 protein elicit higher HBP release and
are subsequently more susceptible to suffering a pathologically
excessive inflammatory response to M1 protein–fibrinogen–IgG
complexes [28]. Direct injection of purified M1 protein is sufficient
to trigger PMN granule-mediated severe lung damage, which is
markedly reduced in neutropenic mice [29]. The M1 protein
structure plays an important role in triggering HBP-mediated lung
injury, as mutated nonfibrinogen-binding M1 protein exhibits
diminished ability to cause pulmonary haemorrhage [30]. The
precise organisation of fibrinogen molecules into a supramolecu-
lar, cross-like network by M1 protein is essential for PMN
activation and is conformationally distinct from normal fibrin clots
[31]. A novel marker of septic shock severity, resistin, has also been
found to predominately originate from M1 protein–activated
PMNs during both systemic and localised severe GAS infection
and contributes to local tissue damage [32].
SLO-mediated inflammatory reactions
Other GAS virulence factors, particularly streptolysin O (SLO),
have been found to modulate PMN responses and contribute to
inflammation and tissue damage. Oligomerization of SLO in
eukaryotic cell membranes forms large (,25–30 nm) pores and
has been shown to disrupt membrane integrity in multiple cell
types, including PMNs, macrophages, and epithelial cells [33,34].
SLO induces toxic PMN platelet aggregates during cutaneous
infection that mediate progression of microvascular thrombosis
and ischemic tissue necrosis [35]. SLO binding by PMNs has also
been shown to mediate HBP, human cathelicidin (LL-37), alpha-
defensin, and elastase release [36]. Multiple accounts indicate that
SLO secretion also facilitates delivery of other GAS virulence
factors. SLO-induced epithelial damage enhanced the penetration
of the GAS SpeA superantigen in a vaginal mucosa model ex vivo
[37]. SLO production also mediates translocation of GAS NAD-
glycohydrolase into host keratinocytes, leading to intracellular
signalling [38].
Host genetic predisposition to excessive immune
responses
The role of host genetic factors contributing to GAS disease has
been investigated and found to play a decisive role in dictating host
susceptibility to severe sepsis and STSS. Goldmann et al. utilised
differential susceptibilities of distinct mouse strains to severe GAS
infection to demonstrate that failure to control infection and
excessive evocation of inflammatory responses by susceptible mice
result in extensive tissue destruction [39]. This finding has been
refined in studies ascribing differences in severity of STSS to host
polymorphism in the human leukocyte antigen complex [13], [40].
Human MHC class II haplotype DRB*1501/DQB1*0602 is less
commonly associated with STSS in the presence of NF, while
DRB1*07/DQB1*0201 predisposes towards such disease mani-
festations [40]. A complementary systems genetics approach was
recently utilized to identify a panel of host genes bestowing
predisposition towards severe GAS sepsis [41]. Pathological levels
of the product of one of these genes, Prostaglandin E, directly
influences the severity of GAS infection [42].
Host Leukocyte Cell Death Responses
Programmed cell death plays a decisive role in determining the
outcome of microbial infections and inflammation. A variety of
regulated cell death mechanisms have been described in response
to infection, which have distinct morphological and molecular
signatures (Box 1).
Apoptotic PMN cell death responses
Apoptosis limits the potential of damaged PMNs to ignite
inflammatory responses [43]. Coordinated PMN apoptotic shut-
down initiates a state of cellular torpor, and administration of
apoptotic PMNs actively promotes anti-inflammatory responses
[44]. Conversely, necrosis triggers a proinflammatory phenotype
resulting in release of damage-associated molecular patterns
(DAMPs) and prompts rapid immune responses [45]. In a landmark
study by Kobayashi et al., phagocytosis-induced PMN transcrip-
tional responses were analysed for a variety of bacterial pathogens,
including GAS [46]. This study provided strong evidence of a
common apoptotic program following bacterial uptake and ROS
production. PMN apoptotic responses are accelerated in GAS and
lead to rapid DNA fragmentation [46]. Although GAS-induced
PMN apoptosis was associated with enhanced virulence potential,
the virulence determinant(s) responsible for this activity were not
elucidated. Later work by the same group indicated PMN apoptosis
induced by phagocytosis of latex beads, as opposed to live bacteria,
is associated with nullified inflammatory capacity and expedites
resolution of inflammation [47].
GAS cytolysin-induced cell death
Several reports emphasize the dominant role of GAS cytolysins
and, to a lesser extent, hyaluronic acid capsule in shaping host cell
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death. Early studies of SLO and streptolysin S (SLS) function
indicate both are capable of inducing plasma membrane
permeabilisation, leading to host epithelial cell lysis [33,48].
GAS strains expressing high and low amounts of SLS were utilised
to demonstrate that SLS expression is associated with caspase-7–
dependent apoptosis of thioglycolate-induced murine PMNs [49].
However, the strains used in this study also differed significantly in
capsule expression, a GAS virulence factor known to influence
PMN phagocytosis. Capsule-deficient, GAS-expressing SLO are
also more readily phagocytosed by DCs, preventing DC matura-
tion by promoting caspase-dependent apoptosis [50]. Proinflam-
matory macrophage cell death consistent with regulated necrosis
(Box 1) was reported by Goldmann et al. [34]. Macrophage
necrosis was attributable to both SLO and SLS activities leading to
glycine sensitive pore formation, loss of mitochondrial outer
membrane potential (ym), ROS production, ATP depletion, and
calpain activation [34]. Conversely, the work of Timmer et al. [51]
found that phagocytosed GAS cytolysin expression also depolarises
ym; however, this leads to DNA fragmentation, cytochrome C
redistribution and caspase-3 and -7 dependent apoptotic cell
death. Macrophages are principally responsible for the clearance
of apoptotic PMNs, and either apoptotic or necrotic depletion of
macrophages may exacerbate damage resulting from GAS-
induced PMN cell death [52]. Apoptotic PMNs not phagocytosed
by macrophages proceed to secondary necrosis and elicitation of
inflammatory responses [53]. These data support an emerging
theme in bacterial pathogenesis [43], and we propose manipula-
tion of phagocyte cell death responses has inflammatory implica-
tions for GAS disease.
GAS interaction with NETs and NETosis
PMNs are able to release extracellular traps (NETs) composed
of DNA, histones, and granule components that ensnare and kill
bacteria [54]. GAS and other bacterial pathogens have evolved
specialized means of evading this host defence mechanism via
secretion of extracellular DNases, which degrade NETs and
enable bacterial survival [55]. In vitro studies have indicated
PMNs undergo a distinct form of cell death following NET release,
dubbed NETosis; however, the relevance of this process to host
defence and bacterial pathogenesis has remained contentious
[56,57]. Recent in vivo evidence obtained using intravital
microscopy indicates that GAS and other gram-positive pathogens
are ensnared by NETosing PMNs; however, these cells, in fact,
remain viable and retain bactericidal capacity [58].
Epithelial Cell Apoptotic Responses
Epithelial cells mediate the first interactions between host and
bacteria. Adherence of GAS to epithelial receptors frequently
precedes intracellular invasion of this bacterium [59], and multiple
Box 1. Modes of Host Regulated Cell Death
Multiple pathways leading to host cell death have been
described and exhibit characteristic morphological, molecu-
lar, and immunological features. Here we briefly summarize
key aspects of host regulated cell death mechanisms
(reviewed in detail in [78,79]).
Apoptosis: Also known as Type-I cell death, apoptosis is a
non-inflammatory cell death mechanism. Apoptosis may be
triggered via multiple external (extrinsic) or internal (intrinsic)
stimuli. Extrinsic apoptosis follows extracellular signalling via
ligands such as Fas/CD95 ligand, TNF-a, and TNF-related
apoptosis inducing ligand (TRAIL) to specific death receptors.
Intrinsic apoptosis can be induced by various intracellular
stresses, including DNA damage and oxidative stress.
Morphologically, apoptotic cells undergo cellular shrinkage,
nuclear condensation, and blebbing. However, more strin-
gent molecular identification of apoptosis considers depen-
dency upon activation of distinct caspases (typically cas-
pases-3, -6, and -7 for extrinsic apoptosis, and caspases-9 and
-3 for intrinsic apoptosis), and the presence of biochemical
features such as mitochondrial membrane depolarization,
oligonucleosomal DNA fragmentation, ROS generation,
exposure of phosphatidylserine, and cellular redistribution
of factors such as cytochrome C and Bax. Apoptotic cells are
generally phagocytosed by macrophages via efferocytosis;
however, if this does not occur, cells may undergo secondary
necrosis, whereby intact apoptotic cells lose plasma mem-
brane integrity and undergo autolysis, triggering immune
responses.
Necrosis: Originally designated ‘‘accidental cell death’’,
necrosis is a proinflammatory cell death mode. While
historically regarded as unintentional cell demise in response
to overwhelming stress, recent works indicate necrosis may
proceed in a regulated fashion (also known as necroptosis or
oncosis). Necrosis is exhibited morphologically via cell and
organelle swelling, cytoplasmic vacuolization, eventual loss
of plasma membrane integrity, and escape of cytoplasmic
content, leading to enhanced immune responses. In some
instances, regulated necrosis has been linked to necrostatin-
inhibitable RIP1-RIP3 activation and/or calpain-cathepsin
activation. Most studies investigating programmed necrosis
have been conducted using non-infectious disease models
(e.g., ischemia-reperfusion); however, a mounting body of
evidence suggests a role for this process in infectious disease
pathogenesis [80,81], and warrants further study.
Autophagic cell death: Also known as Type-II cell death,
autophagic cell death is a non-inflammatory cell death
response. Cellular autophagy can be triggered by cells under
specific stresses, including endoplasmic reticulum stress or
starvation, and are distinguished via the formation of
cytoplasmic double-membraned vesicles known as autopha-
gosomes. Autophagosomes typically contain damaged
organelles or cytoplasmic material, are labelled with LC3,
and eventually fuse with lysosomes (acquiring the LAMP-1
marker), leading to degradation of autophagosomal con-
tents. Autophagic responses that accompany cell death have
been associated with a distinct programmed cell death
routine; however, an increasing body of evidence supports
the supposition that autophagy primarily exerts a protective
response against cell demise in vivo.
Pyroptosis: Pyroptosis describes a specific form of pro-
inflammatory cell death sharing characteristics of both
apoptosis and necrosis. Pyroptotic activation of macrophag-
es and other cell types by microbial and nonmicrobial agents
is dependent on activation of caspase-1, which proteolyti-
cally drives maturation and release of IL-1b and IL-18.
Caspase-1 activation is associated with the formation of large
multiprotein complexes, either the inflammasome or pyr-
optosome, which involves signalling via NLRPs and the ASC
adaptor protein. These events culminate in cytoplasmic
swelling and osmotic lysis of pyroptotic cells, which
combined with increased IL-1b and IL-18 release, enhances
immune reactions.
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pathways of epithelial cell death have been reported following
GAS infection (Figure 2A). GAS infection of A549 and HEp-2
cells was found to elicit morphological changes consistent with
apoptosis, attributable to the activity of GAS cysteine protease
SpeB [60]. The apoptotic Fas receptor (FasR) and avb3 integrins
are able to bind SpeB, leading to downstream caspase-8 activation
and translocation of truncated-Bid (tBid) and Bax to mitochondria
[61,62]. Binding of SpeB to host receptors also up-regulates
caspase-8 and Bax via JAK-STAT, p38, and p53 signalling
[63,64]. Internalization-dependent epithelial cell apoptosis in
response to GAS infection has also been reported, whereby
fibronectin-mediated binding of GAS to host integrins triggers
actin rearrangement and Rac1 activation [65,66]. Rac1 activation
is hypothesized to mediate epithelial cell ROS production, leading
to downstream apoptotic responses [65–66]. A third pathway
trigged by extracellular GAS also elicits epithelial apoptosis via an
SLO-dependent mechanism [67]. Secretion of SLO by encapsu-
lated GAS triggers calcium flux into the cytosol of infected cells,
leading to vacuolization of the endoplasmic reticulum and cell
apoptosis [67]. Central to these pathways is the role of the
mitochondria, as cytochrome c release and ym depolarisation are
described as key events, and that overexpression of the anti-
apoptotic factor Bcl-2 can inhibit mitochondrial dysfunction. In
many studies, both capase-9 and caspase-3 are reported to mediate
the final apoptotic cascade. Transcriptional analyses of epithelial
cells also indicate overall apoptotic responses to GAS infection,
and that GAS elicits up-regulation of caspases and calcium
regulators [68,69]. It is important to note that different GAS
Figure 2. Epithelial cellular responses to GAS infection. A GAS-induced apoptosis of epithelial cells is triggered via intrinsic and extrinsic
pathways. SpeB binding to epithelial avb3 integrins or the Fas receptor (FasR) triggers upregulation of caspase-8 (casp-8) via JAK2, p38, p53, and
STAT1 signalling [62–64]. Procaspase-8 (pro-casp-8) is also activated directly due to FasR signalling, leading to truncation of cytosolic Bid (tBid) and
translocation of tBid to the mitochondria. Extracellular GAS binding to host integrins is enabled via bridging molecules such as fibronectin (Fn), and
enables Rac1-mediated internalization of GAS into host epithelial cells. GAS internalization and Rac1 activation facilitates production of ROS, leading
to increased p38 phosphorylation [65,66]. Encapsulated extracellular GAS are not internalized by epithelial cells, and secrete the pore-forming toxin
SLO. Integration of SLO into host cell membranes triggers net calcium (Ca++) flux into the cytosol and endoplasmic reticulum (ER) stress [67]. All three
pathways elicit loss of mitochondrial outer membrane potential (ym) and release of cytochrome C from the mitochondria, which precedes activation
of caspase-9 (casp-9), caspase-3 (casp-3), and apoptosis. Overexpression of the anti-apoptotic factor Bcl-2 by the host can inhibit epithelial cell
apoptosis. B GAS evades xenophagic killing by epithelial cells. GAS binding to the CD46 receptor is an early signal to activate autophagic responses
[72], and GAS are uptaken into early endosomes in a Rab5-dependent manner [74]; however, SLO expression allows GAS to escape from endosomes
into the cytosol. GAS exposure to the cytosol is recognized via ubiquitin (Ub) adapter proteins that, in conjunction with Rab7 and Rab23, facilitate
shuttling of GAS into GcAVs bearing the classic autophagy LC3 marker [71,73]. In the absence of SLO, streptolysin S is sufficient to damage
endosomal vacuoles for targeting to GcAVs by Ub-independent, galectin-8-mediated autophagy [76]. Lysosomal fusion with GcAVs, via Rab7 and
Rab9a, effects xenophagic destruction of intracellular GAS. Expression of SpeB by cytosolic GAS degrades Ub adapter proteins and prevents targeting
of bacteria to GcAVs, enhancing intracellular GAS survival [77]. Secretion of GAS NADase also protects GAS from xenophagic killing by inhibiting
fusion of GcAVs with lysosomes [76].
doi:10.1371/journal.ppat.1004266.g002
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serotypes do not elicit uniform epithelial responses, and compar-
ison of apoptotic induction by disparate GAS strains demonstrates
multiple caspases are utilized [70].
GAS-Induced Autophagy
Epithelial cell apoptosis has been suggested to protect host cells
from infection; however, data validating this hypothesis is lacking,
and contention exists regarding whether epithelial apoptotic cell
death is, indeed, a protective host response or a pathogenic
mechanism utilized by GAS [66,67]. An alternative epithelial cell
defence mechanism against GAS infection has been recently
described. Autophagy, a stress response wherein damaged cellular
components are targeted to degradative endosomal vacuoles, can
protect cells from intracellular GAS (Figure 2B). HeLa cells
containing intracellular M6 serotype GAS recognize cytosol-
exposed bacteria and target them for autophagic degradation via
ubiquitinylation, LC3 labelling, and the formation of GAS-
containing, autophagosome-like vacuoles (GcAVs) [71]. Expres-
sion of SLO by intracellular GAS is crucial for GAS escape from
endosomes into the cytosol and subsequent targeting to GcAVs
[71]. Binding of the cell surface CD46 receptor is an early trigger
of GAS-mediated autophagy [72]. The Rab-family of G-proteins
is responsible for multiple aspects of GcAV formation. Rab7
protein performs numerous roles, including targeting of GAS to
GcAVs and initial GcAV formation, and autophagosomal
maturation [73]. Other Rab-enzymes, Rab5, Rab23, and Rab9a,
also play distinct roles, which include facilitating GAS uptake into
endosomes, targeting of GAS to GcAVs, fusion of nascent GcAVs,
and autophagosomal maturation [74,75]. Recent studies report
that GAS is able to subvert autophagy-mediated bacterial
destruction (also called xenophagy) for intracellular survival.
SLO-mediated translocation of GAS NADase prevents efficient
killing of serotype M6 GAS via inhibition of autophagosomal
fusion with lysosomes [76]. A novel ubiquitin-independent
pathway of GcAV formation was also described for primary
human keratinocytes in this study, mediated by SLS damage to
endosomal vacuoles leading to galectin-8 labelling [76]. Infection
of HEp-2 cells with M1T1 serotype GAS reveals significantly
greater intracellular survival than by M6 GAS, with M1T1 GAS
displaying exposure to the cell cytosol but lack of the LC3
autophagy marker [77]. Enhanced M1T1 GAS survival was found
to be directly linked to SpeB activity, which degrades cytosolic
ubiquitin and the adapter proteins NDP52, p62, and NBR1 to
effect highly efficient evasion of cellular xenophagy [77].
Discussion
Detailed understanding of the host cellular processes that
precipitate severe GAS disease is vital to the development of
improved treatment strategies. Host receptor binding to GAS-
derived ligands activates PMNs and pro-inflammatory signalling
cascades of other cell types, which result in the release of host
molecules such as HBP, cytokines and resistin. Excessive exposure
of these factors is associated with multiple hallmarks of severe GAS
disease, including increased vascular permeability, systemic
inflammatory responses and destruction of focal tissues. GAS
and GAS cytolysin induction of regulated cell death of leukocytes,
leading to increased DAMP release, may further contribute to the
virulence and inflammatory potential of this pathogen. While
GAS-induced, host leukocyte apoptotic, and regulated necrotic
cell death may contribute to GAS disease pathologies, regulated
epithelial cell death responses could serve a more protective role,
as epithelial xenophagy directly counters GAS intracellular
invasion. However, as recent studies illustrate, GAS is able to
prevent intracellular killing, and so apoptosis of epithelial cells may
serve as a host contingency response, as these cells will be taken up
by nearby phagocytes. Thus, therapeutic interventions that reduce
the exposure of inflammatory mediators and/or restore native cell
death processes may help alleviate pathologies of severe GAS
infection.
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